Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients-Reference-Cited by-同舟云学术

Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients

Published:2019-09-23 Issue:9 Volume:14 Page:e0222709
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fragoso-Ontiveros Veronica,Velázquez-Aragón Jose Antonio^ORCID,Nuñez-Martínez Paulina Maria,de la Luz Mejía-Aguayo Maria,Vidal-Millán Silvia,Pedroza-Torres Abraham,Sánchez-Contreras Yuliana,Ramírez-Otero Miguel Angel,Muñiz-Mendoza Rodolfo,Domínguez-Ortíz Julieta,Wegman-Ostrosky Talia,Bargalló-Rocha Juan Enrique,Gallardo-Rincón Dolores,Reynoso-Noveron Nancy,Arriaga-Canon Cristian,Meneses-García Abelardo,Herrera-Montalvo Luis Alonso,Alvarez-Gomez Rosa Maria^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Breast cancer susceptibility genes BRCA1 and BRCA2;LC Brody;Medicine,1998

2. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2;MC King;Science,2003

3. BRCA1 and BRCA2: 1994 and beyond;SA Narod;Nat Rev Cancer,2004

4. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE;N Mavaddat;J Natl Cancer Inst,2013

5. The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families;MD Palma;Cancer Res,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Molecular Characterization of the Allelic Expression of the BRCA1 Founder Δ9–12 Pathogenic Variant and Its Potential Clinical Relevance in Hereditary Cancer;International Journal of Molecular Sciences;2024-06-20

2. Germline Testing Around the Globe: Challenges in Different Practice Settings;American Society of Clinical Oncology Educational Book;2023-05

3. Using species richness calculations to model the global profile of unsampled pathogenic variants: Examples from BRCA1 and BRCA2;PLOS ONE;2023-02-08

4. Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico;Genes;2023-01-28

5. Using species richness calculations to model the global profile of unsampled pathogenic variants: Examples fromBRCA1andBRCA2;2022-11-13